Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Background & aims Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit
SARS-CoV-2, in vitro and in vivo. In absence of any effective treatment for SARS-CoV-2 …
被引用次数：220 相关文章

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

AK Singh, A Singh, R RituSingh, A Misra - 2020 - expeditiorepositorio.utadeo.edu.co
Background & aims Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit
SARS-CoV-2, in vitro and in vivo. In absence of any effective treatment for SARS-CoV-2 …

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

AK Singh, A Singh, R Singh… - Diabetes & metabolic …, 2020 - pubmed.ncbi.nlm.nih.gov
Background & aims Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit
SARS-CoV-2, in vitro and in vivo. In absence of any effective treatment for SARS-CoV-2 …

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic …, 2020 - europepmc.org
Methods We systematically searched the PubMed, ClinicalTrial. Org and MedRxiv database
up till May 5, 2020 using specific key words such as" Remdesivir" or'GS-5734 ″AND" …
[HTML] nih.gov

[HTML][HTML] Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic …, 2020 - ncbi.nlm.nih.gov
Methods We systematically searched the PubMed, ClinicalTrial. Org and MedRxiv database
up till May 5, 2020 using specific key words such as “Remdesivir” or 'GS-5734 ″AND …

[引用][C] Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic Syndrome …, 2020 - cir.nii.ac.jp
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF] researchgate.net

[PDF][PDF] Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

AK Singha, A Singhb, R Singhc, A Misrad - 2020 - researchgate.net
Background & aims: Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit
SARS-CoV-2, in vitro and in vivo. In absence of any effective treatment for SARS-CoV-2 …

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.

AK Singh, A Singh, R Singh, A Misra - Diabetes & Metabolic …, 2020 - europepmc.org
Methods We systematically searched the PubMed, ClinicalTrial. Org and MedRxiv database
up till May 5, 2020 using specific key words such as" Remdesivir" or'GS-5734 ″AND" …